ANDA 90386, held by Am Regent. Metoprolol Tartrate.
As of Nov 22, 2026, ANDA 90386 (Metoprolol Tartrate), held by Am Regent, was first approved by FDA on Sep 30, 2009, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 30, 2009 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metoprolol Tartrate1MG/ML · injectable;injection | Metoprolol Tartrate | Discontinued |
| Nov 12, 2024 | Supplement 4Labeling · Standard review | Approved | None posted |
| Oct 30, 2019 | Supplement 3Labeling · Standard review | Approved | None posted |
| Jun 29, 2010 | Supplement 1Labeling | Approved | None posted |
| Sep 30, 2009 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters